PT1973527E - Processos de produção de formulações farmacêuticas à base de partículas destinadas a administração parentérica - Google Patents
Processos de produção de formulações farmacêuticas à base de partículas destinadas a administração parentérica Download PDFInfo
- Publication number
- PT1973527E PT1973527E PT06840263T PT06840263T PT1973527E PT 1973527 E PT1973527 E PT 1973527E PT 06840263 T PT06840263 T PT 06840263T PT 06840263 T PT06840263 T PT 06840263T PT 1973527 E PT1973527 E PT 1973527E
- Authority
- PT
- Portugal
- Prior art keywords
- blend
- particles
- parenteral administration
- processes
- pharmaceutical agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75046105P | 2005-12-15 | 2005-12-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1973527E true PT1973527E (pt) | 2010-01-04 |
Family
ID=38163638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT06840263T PT1973527E (pt) | 2005-12-15 | 2006-12-14 | Processos de produção de formulações farmacêuticas à base de partículas destinadas a administração parentérica |
Country Status (10)
Country | Link |
---|---|
US (1) | US20070178165A1 (pt) |
EP (1) | EP1973527B1 (pt) |
JP (1) | JP2009519973A (pt) |
AT (1) | ATE444736T1 (pt) |
CA (1) | CA2631494A1 (pt) |
DE (1) | DE602006009710D1 (pt) |
DK (1) | DK1973527T3 (pt) |
ES (1) | ES2334164T3 (pt) |
PT (1) | PT1973527E (pt) |
WO (1) | WO2007070852A2 (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2014MN00380A (pt) | 2006-06-30 | 2015-06-19 | Iceutica Pty Ltd | |
TWI405590B (zh) * | 2007-04-06 | 2013-08-21 | Activus Pharma Co Ltd | 微粉碎化有機化合物粒子之製法 |
US8741918B2 (en) * | 2007-06-21 | 2014-06-03 | Veroscience Llc | Parenteral formulations of dopamine agonists |
US20100035886A1 (en) * | 2007-06-21 | 2010-02-11 | Veroscience, Llc | Parenteral formulations of dopamine agonists |
WO2009073215A1 (en) * | 2007-12-06 | 2009-06-11 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
WO2010002613A2 (en) * | 2008-07-02 | 2010-01-07 | 3M Innovative Properties Company | Method of making a dry powder pharmaceutical composition |
MY177537A (en) * | 2009-04-24 | 2020-09-17 | Iceutica Pty Ltd | Production of encapsulated nanoparticles at commercial scale |
SG175308A1 (en) * | 2009-04-24 | 2011-11-28 | Iceutica Pty Ltd | Method for improving the dissolution profile of a biologically active material |
AU2014208310C1 (en) * | 2009-04-24 | 2020-01-23 | Iceutica Pty Ltd | A Novel Formulation of Diclofenac |
EP3290030A1 (en) * | 2009-04-24 | 2018-03-07 | Iceutica Pty Ltd. | Diclofenac formulation |
DK2421513T3 (en) | 2009-04-24 | 2018-03-26 | Iceutica Pty Ltd | UNKNOWN FORMULATION WITH INDOMETHACIN |
BRPI1012980A2 (pt) * | 2009-05-19 | 2016-03-29 | Vivia Biotech Sl | dispositivo e métodos para analisar a capacidade de resposta celular e a resposta de células neoplásticas a drogas |
WO2012094381A2 (en) | 2011-01-05 | 2012-07-12 | Hospira, Inc. | Spray drying vancomycin |
KR20140041453A (ko) | 2011-02-25 | 2014-04-04 | 사우스다코타주립대학 | 국소적 전달을 위한 단백질 나노 캐리어 |
US20130172271A1 (en) * | 2012-01-04 | 2013-07-04 | Cynthia Fragale | Pharmaceutical Spray Drying |
CN104043104B (zh) | 2013-03-15 | 2018-07-10 | 浙江创新生物有限公司 | 含盐酸万古霉素的喷雾干粉及其工业化制备方法 |
US9526734B2 (en) | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
CN104288104A (zh) * | 2014-09-24 | 2015-01-21 | 万特制药(海南)有限公司 | 奥卡西平干混悬剂及其制备方法 |
EP3233055A1 (en) * | 2014-12-20 | 2017-10-25 | Troikaa Pharmaceuticals Ltd | Injectable formulations of paracetamol |
WO2020023507A1 (en) * | 2018-07-23 | 2020-01-30 | Cornell University | Natural fluorescent polyhedral amino acid crystals for efficient entrapment and systemic delivery of hydrophobic small molecules |
JP2022506128A (ja) | 2018-10-30 | 2022-01-17 | ビーエーエスエフ ソシエタス・ヨーロピア | 活性材料が装填された微粒子を製造する方法 |
CN111904947A (zh) * | 2019-05-07 | 2020-11-10 | 江苏恒瑞医药股份有限公司 | 一种注射用药物组合物及其制备方法 |
BR112021023788A2 (pt) | 2019-07-12 | 2022-02-08 | Basf Se | Processo para produzir micropartículas, composição de micropartículas, produto, e, uso da composição |
CN113440529B (zh) * | 2020-03-25 | 2023-11-14 | 江苏恒瑞医药股份有限公司 | 一种可注射的药物组合物及其制备方法 |
US20220168272A1 (en) * | 2021-02-22 | 2022-06-02 | Gholamhossein Yousefi | Preparation of soluble form of carvedilol |
WO2024038046A1 (en) | 2022-08-18 | 2024-02-22 | Basf Se | Process for producing microparticles |
WO2024115355A1 (en) | 2022-11-28 | 2024-06-06 | Basf Se | Conjugates of polysaccharides and hydrophobic compounds as emulsion stabilizers |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5370878A (en) * | 1993-09-30 | 1994-12-06 | Hallmark Pharmaceuticals, Inc. | Method for preparing a direct compression granulated acetaminophen composition |
US5612053A (en) * | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US5811406A (en) * | 1995-06-07 | 1998-09-22 | Regents Of The University Of California | Dry powder formulations of polynucleotide complexes |
US7029700B2 (en) * | 2000-01-14 | 2006-04-18 | Brown University Research Foundation | Micronized freeze-dried particles |
US20040121003A1 (en) * | 2002-12-19 | 2004-06-24 | Acusphere, Inc. | Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
WO2004064752A2 (en) * | 2003-01-22 | 2004-08-05 | Alkermes Controlled Therapeutics, Inc. | Method of preparing sustained release microparticles |
-
2006
- 2006-12-14 DE DE602006009710T patent/DE602006009710D1/de active Active
- 2006-12-14 ES ES06840263T patent/ES2334164T3/es active Active
- 2006-12-14 PT PT06840263T patent/PT1973527E/pt unknown
- 2006-12-14 DK DK06840263.5T patent/DK1973527T3/da active
- 2006-12-14 AT AT06840263T patent/ATE444736T1/de active
- 2006-12-14 US US11/610,791 patent/US20070178165A1/en not_active Abandoned
- 2006-12-14 WO PCT/US2006/062094 patent/WO2007070852A2/en active Application Filing
- 2006-12-14 CA CA002631494A patent/CA2631494A1/en not_active Abandoned
- 2006-12-14 JP JP2008545975A patent/JP2009519973A/ja active Pending
- 2006-12-14 EP EP06840263A patent/EP1973527B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2334164T3 (es) | 2010-03-05 |
WO2007070852A2 (en) | 2007-06-21 |
WO2007070852A3 (en) | 2007-11-01 |
ATE444736T1 (de) | 2009-10-15 |
DK1973527T3 (da) | 2010-02-01 |
EP1973527B1 (en) | 2009-10-07 |
US20070178165A1 (en) | 2007-08-02 |
DE602006009710D1 (de) | 2009-11-19 |
EP1973527A2 (en) | 2008-10-01 |
JP2009519973A (ja) | 2009-05-21 |
CA2631494A1 (en) | 2007-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1973527E (pt) | Processos de produção de formulações farmacêuticas à base de partículas destinadas a administração parentérica | |
WO2007070843A3 (en) | Processes for making particle-based pharmaceutical formulations for oral administration | |
WO2007070851A3 (en) | Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration | |
WO2011112900A3 (en) | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof | |
WO2009122301A3 (en) | Rasagiline mesylate particles and process for the preparation thereof | |
WO2009026461A3 (en) | Thermo-kinetic mixing for pharmaceutical applications | |
WO2006113505A3 (en) | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same | |
UA90708C2 (ru) | Таблетки с улучшенной дисперсностью лекарственного вещества | |
WO2009032246A3 (en) | Particulate compositions for delivery of poorly soluble drugs | |
CA2430318A1 (en) | Powder formulation and method for producing the same | |
WO2007150075A3 (en) | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone | |
WO2007133751A3 (en) | Base-stabilized polyorthoester formulations | |
WO2008024485A3 (en) | Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent | |
UA95088C2 (ru) | Композиция, которая содержит наночастички связанные с биосовместимым полимером противоракового агента и снижает аллопецию при химиотерапии, способ ее получения | |
WO2008069938A3 (en) | Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide | |
WO2007120838A3 (en) | Rapidly disintegrating solid oral dosage form of liquid dispersions | |
AU2014226192A8 (en) | Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles | |
WO2014167579A3 (en) | Stable pharmaceutical compositions of tadalafil | |
WO2007056177A3 (en) | T315a and f317i mutations of bcr-abl kinase domain | |
HK1120739A1 (en) | Oral solid pharmaceutical formulation of the tribulin inhibitor indibulin | |
WO2006030301A8 (en) | Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers | |
WO2007089926A3 (en) | Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution | |
WO2007128495A3 (en) | Solid pharmaceutical composition of gabapentin | |
WO2011146852A8 (en) | Foams or particles for applications such as drug delivery | |
CN106913537A (zh) | 一种醋酸阿比特龙舌下片剂及其制备方法 |